logo

For the Inventor, By the Inventor

Ibaraki, Japan

Makoto Oka

USPTO Granted Patents = 10

Average Co-Inventor Count = 5.5

ph-index = 4

Forward Citations = 172(Granted Patents)


Company Filing History:

goldMedal10 out of 129 
 
Dainippon Pharmaceutical Company, Limited
 patents

Years Active: 1991-2002

Loading Chart...
10 patents (USPTO):Explore Patents
1. 6372740 - 2-aryl-8-oxodihydropurine derivative, process for the producing the same, medicinal compositions containing the same, and intermediates thereof (2002-04-16),
2. 6277993 - Intermediates for 5-substituted-3-oxadiazolyl-1,6-Naphthyridin-2(1H)-one derivatives (2001-08-21),
3. 6172079 - 5-substituted-3-oxadiazolyl-1,6-naphthyridin-2(1H)-one derivatives (2001-01-09),
4. 5972946 - Acetamide derivative, process for preparing the same, and a (1999-10-26),
5. 5424434 - Production on 3-oxadiazolyl-1,6-naphthyridine derivatives (1995-06-13),
6. 5424433 - Intermediates for 3-oxadiazoly-1,6-naphthyridine derivatives (1995-06-13),
7. 5367078 - 3-oxadiazolyl-1,6-naphthyridine derivatives (1994-11-22),
8. 5185338 - Medicament for treating cerebral insufficiency diseases, novel (1993-02-09),
9. 5041443 - Medicament for treating cerebral insufficiency diseases, novel (1991-08-20),
10. 5021421 - 2-(1-Piperazinyl)-4-phenylcycloalkanopyridine derivatives, processes for (1991-06-04),

Title: The Innovative Contributions of Makoto Oka

Introduction

Makoto Oka is a prominent inventor based in Ibaraki, Japan. He has made significant contributions to the field of medicinal chemistry, holding a total of 10 patents. His work focuses on developing novel compounds that have potential therapeutic applications.

Latest Patents

Among his latest patents are the "2-aryl-8-oxodihydropurine derivative, process for the producing the same, medicinal compositions containing the same, and intermediates thereof" and "Intermediates for 5-substituted-3-oxadiazolyl-1,6-Naphthyridin-2(1H)-one derivatives." These innovations highlight his expertise in creating complex chemical structures that may lead to new medicinal therapies.

Career Highlights

Makoto Oka has had a distinguished career, working with Dainippon Pharmaceutical Company, Limited. His role at the company has allowed him to focus on research and development, contributing to advancements in pharmaceutical sciences.

Collaborations

Throughout his career, Oka has collaborated with notable colleagues, including Kiyoshi Furukawa and Kazunori Ohno. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Makoto Oka's contributions to medicinal chemistry through his patents and collaborations underscore his importance in the field. His work continues to pave the way for future advancements in pharmaceutical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…